- Home
- NAZ vs INO Comparison
NAZ vs INO Comparison
Compare NAZ & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAZ
- INO
- Stock Information
- Founded
- NAZ 1992
- INO 1979
- Country
- NAZ United States
- INO United States
- Employees
- NAZ N/A
- INO N/A
- Industry
- NAZ Finance/Investors Services
- INO Medical/Dental Instruments
- Sector
- NAZ Finance
- INO Health Care
- Exchange
- NAZ Nasdaq
- INO Nasdaq
- Market Cap
- NAZ 135.7M
- INO 110.7M
- IPO Year
- NAZ N/A
- INO 1998
- Fundamental
- Price
- NAZ $12.06
- INO $4.30
- Analyst Decision
- NAZ
- INO Buy
- Analyst Count
- NAZ 0
- INO 6
- Target Price
- NAZ N/A
- INO $21.00
- AVG Volume (30 Days)
- NAZ 18.3K
- INO 320.4K
- Earning Date
- NAZ 01-01-0001
- INO 11-14-2024
- Dividend Yield
- NAZ 3.69%
- INO N/A
- EPS Growth
- NAZ N/A
- INO N/A
- EPS
- NAZ N/A
- INO N/A
- Revenue
- NAZ N/A
- INO $203,413.00
- Revenue This Year
- NAZ N/A
- INO N/A
- Revenue Next Year
- NAZ N/A
- INO N/A
- P/E Ratio
- NAZ N/A
- INO N/A
- Revenue Growth
- NAZ N/A
- INO N/A
- 52 Week Low
- NAZ $9.22
- INO $4.20
- 52 Week High
- NAZ $11.37
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- NAZ 57.90
- INO 23.84
- Support Level
- NAZ $11.56
- INO $5.25
- Resistance Level
- NAZ $12.36
- INO $5.60
- Average True Range (ATR)
- NAZ 0.24
- INO 0.27
- MACD
- NAZ 0.05
- INO -0.08
- Stochastic Oscillator
- NAZ 29.83
- INO 1.11
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.